Synthetic peptides containing ITIM-like domains block expression of inflammatory mediators and migration/invasion of cancer cells through activation of SHP-1 and PI3K

Cancer Investigation
Jae-Kwan KimWon-Ha Lee

Abstract

Increasing evidence supports that inflammation is closely associated with the development of cancer. In an effort to develop synthetic peptides that can suppress the inflammatory activation of cancer cells, decapeptides representing immunoreceptor tyrosine-based inhibitory motif (ITIM)-like sequences of immune receptor expressed on myeloid cells-1 (IREM-1) were tested for their anti-inflammatory effects in cancer cell lines. One (named TAT-YADL) out of the five synthetic peptides tested exhibited inhibitory effects on the expression of inflammatory mediators as well as invasion and migration. The inhibitory activities of the synthetic peptides required activation of SH2-containing protein tyrosine phosphatase-1 (SHP-1) and phosphoinositide 3-kinase (PI3K).

References

Apr 8, 2003·Current Protein & Peptide Science·E VivèsB Lebleu
Dec 10, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Dong-Hui ChungMichael R Daws
Jan 8, 2004·The Journal of Biological Chemistry·Andrew StreetMark Harris
Apr 22, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Derek StrassheimEdward Abraham
Jun 12, 2004·Journal of Biomolecular Screening·Christopher RosenauM Walid Qoronfleh
Sep 17, 2004·Cell·Hans Clevers
Oct 19, 2004·Seminars in Cancer Biology·Mary PhilipHans Schreiber
Nov 19, 2004·European Journal of Immunology·Damiana Alvarez-ErricoMiguel López-Botet
Feb 21, 2006·Biochemical and Biophysical Research Communications·Amy O HardinB Keith English
Apr 11, 2006·Molecular Cancer Research : MCR·Haitian LuChuanshu Huang
Sep 13, 2006·Cancer Metastasis Reviews·Alberto MantovaniAntonio Sica
Jan 5, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Damiana Alvarez-ErricoMiguel López-Botet
May 2, 2008·Cancer Letters·Antonio SicaAlberto Mantovani
Jul 25, 2008·Nature·Alberto MantovaniFrances Balkwill
Mar 18, 2009·PloS One·Kushagra BansalKithiganahalli Narayanaswamy Balaji
Mar 18, 2009·Immunological Reviews·Ulrike Lorenz
Apr 29, 2009·Laboratory Investigation; a Journal of Technical Methods and Pathology·George P ChristophiPaul T Massa
Jun 30, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kumi IzawaToshio Kitamura
Dec 30, 2009·The Journal of Experimental Medicine·Hongkang XiMenno van Lookeren Campagne
Jun 3, 2010·Current Topics in Microbiology and Immunology·Elisabeth FayardBrian A Hemmings
May 4, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sang-Min LeeWon-Ha Lee

❮ Previous
Next ❯

Citations

Nov 28, 2013·International Journal of Endocrinology·Ewa MatuszczakWojciech Debek
Mar 29, 2016·Journal of Cellular Physiology·Ya-Hui Chiu, Christopher T Ritchlin

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here